PATIENTS FIRST
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

PATIENTS FIRST Trademark

Serial Number: 99492717

PATIENTS FIRST is a trademark filed by Hercules Pharmaceuticals, Inc. on November 12, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Hercules Pharmaceuticals, Inc.

27 Seaview Boulevard
Port Washington, NY 11050

Entity Type: 03

Trademark Details

Filing Date

November 12, 2025

Registration Date

Not Registered

Goods & Services

Wholesale distributorship services featuring prescription and non-prescription pharmaceutical products, medical devices, and other FDA-regulated products for licensed pharmacies, hospitals, healthcare systems, and other institutional purchasers; wholesale ordering services in the field of prescription and non-prescription pharmaceutical preparations, dietary supplements, and medical devices for institutional purchasers; wholesale services by direct solicitation by sales agents in the field of prescription and non-prescription pharmaceutical preparations, dietary supplements, and medical devices for institutional purchasers; on-line wholesale store services featuring prescription and non-prescription pharmaceutical preparations, dietary supplements, and medical devices for institutional purchasers.

Providing health information to pharmacies and healthcare providers in the field of medication adherence, safe use of pharmaceuticals, and patient safety

Quality control of pharmaceutical wholesale distribution services of others.

Providing educational services, namely, conducting information sessions in the nature of live presentations by educational speakers and training programs, directed to pharmacies and healthcare providers, in the field of pharmaceutical wholesaling and distribution best practices, patient safety, and medication adherence.

FDA-regulated pharmaceutical products, namely, brand medicine, generic medicine, biologics and biosimilars, orphan drugs, over-the-counter drugs, controlled substances, vitamins, and supplements for the treatment of cardiovascular diseases; neurological disorders; psychiatric and psychological conditions; infectious diseases, namely, viral, bacterial, and fungal infections; HIV and hepatitis; oncological diseases and malignancies; dermatological conditions; pulmonary and respiratory disorders; nephrological diseases; gastrointestinal and hepatic conditions; hematologic disorders; reproductive and fertility-related conditions; immunological and allergic conditions; endocrine and metabolic disorders, namely, diabetes; musculoskeletal and orthopedic conditions; ophthalmologic disorders; transplant-related conditions and post-operative complications; all for the management of pain and other chronic or acute medical conditions.

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 18, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 18, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 18, 2026 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jul 1, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jul 1, 2026 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 1, 2026 GNRN
NON-FINAL ACTION E-MAILED
Apr 1, 2026 GNRT
NON-FINAL ACTION WRITTEN
Apr 1, 2026 CNRT
ASSIGNED TO EXAMINER
Mar 22, 2026 DOCK
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Dec 18, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 18, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 18, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 18, 2025 REAP
APPLICATION FILING RECEIPT MAILED
Nov 12, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 12, 2025 NWOS
NEW APPLICATION ENTERED
Nov 12, 2025 NWAP